The INHALE-3 trial (2024) compared the efficacy of an inhaled insulin regimen (Afrezza) plus long acting degludec insulin against usual care over 17 weeks among 123 adults. More participants using the ...

Many drugs, including insulin, essentially became free. But the American Rescue Plan made a major change that hit drug companies with even larger penalties for raising prices. In January 2024 ...

While this option may be less expensive and seems convenient, it’s best to consult a doctor about dosage if you use it, says Joshua J. Neumiller, CDCES, PharmD, the president elect of ...

However, studies suggest that almost half of all people using automatic insulin pumps fail to achieve this," explains Dr. Michael Tsoukas, principal investigator of the study, Investigator in the ...

Gavin Newsom in 2023 announced a partnership with Civica Rx to provide insulin to Californians for $30 for 10 milliliters, which he said was as little as one-tenth of the cost at the time. Photo by ...

Researchers from Lund University and Newcastle University have found that the protein IGFBP7 can impair the function of beta ...

Patients with differing levels of insulin resistance and ß-cell reserve may respond differently to self-monitoring and changes in diabetes control regimens. The true impact of self-monitoring ...

Apart from Victoza, which was approved for Type 2 diabetes in 2010, liraglutide also underpins Novo’s older weight loss drug Saxenda and its insulin-degludec-based diabetes combination therapy ...